About Xeris Pharmaceuticals (XERS)

Xeris Pharmaceuticals Inc (XERS) is a pharmaceutical company focused on developing and commercializing innovative injectable and infusible drug formulations. The company's mission is to improve patient care through its proprietary drug delivery technologies and formulation expertise. Xeris Pharmaceuticals is known for its groundbreaking work in the field of diabetes management, with a portfolio of products specifically designed to address the challenges faced by patients with this chronic condition. The company's flagship product, Gvoke, is the first ready-to-use, room-temperature stable liquid glucagon for the treatment of severe hypoglycemia. This breakthrough product eliminates the need for reconstitution and refrigeration, making it more convenient for patients and caregivers.

In addition to its focus on diabetes, Xeris Pharmaceuticals is also developing innovative therapies for other underserved patient populations. The company's pipeline includes potential treatments for epilepsy, hypoparathyroidism, and other rare diseases. Xeris Pharmaceuticals is committed to advancing the standard of care for these conditions through its novel drug delivery technologies. By leveraging its expertise in formulation and its deep understanding of patient needs, the company aims to bring novel therapies to market that can truly make a difference in the lives of patients.